Interleukin 2 (IL2)
Cancer strikes anxiety and fear in the minds of many. Nowadays, Cancer is known to be one of the most common lethal disease in the world. However, recently there has been a breakthrough in harnessing the immune system to treat malignant tumors.
Cytokines are small glycoproteins that bind to cell surface receptors and regulate the development, survival and function of the immune cell. Therefore, cytokines have been extensively studied as potential therapeutic agents to manipulate the immune response to tumor cells.
Interleukin 2 (IL-2) is one of the key cytokines with pleiotropic effects on the immune system. Interleukin 2 (IL-2) is required for the activation, growth and differentiation of several families of immune cells which includes, T lymphocytes, B lymphocytes and the natural killer (NK) cells.
Currently, the main indication of Interleukin 2 (IL-2) includes the treatment of metastatic renal cell carcinoma and melanoma for which high-dose intravenous regimens comes highly recommended.